Overview
We support in all stages of the International Marketing process: from the identification and assessment of international portfolio to finding most suitable local partner. With our longstanding network and knowledge of the industry, we can assist in the development of international Pharmaceutical Market, which will save both time and money.
MEX PHARMA is actively and constantly seeking to optimize their business strategies in order to increase company growth and revenue. We develop successful international Pharma Strategies and supports new market entries in emerging markets all over the world.
Global market dynamics compel healthcare companies to adjust to the demands of globalization, and an international Pharma Strategy is needed to ensure growth and achieve their ambitions.To achieve growth through international sales while simultaneously fostering current business, MEX PHARMA mainly focus and investment is from home markets to international and emerging markets.
Markets
MEX PHARMA foucuses on Emerging markets with promising annual growth rates and a great deal of development potential. As a result, many highly profitable business opportunities are being created for companies and investors.
We are in emerging market and have good chances of success, as the markets in Russia, Ukraine, Turkey, Brazil, Mexico, Indonesia, South Korea, the Philippines, Colombia, India, Poland etc. all have great potential for the pharmaceutical industry and international investors.
MEX PHARMA sees value in focusing on international pharmaceutical market and their processes. Our assessments are on the best-fit products in most promising markets. MEX PHARMA has a wide product portfolio as part of international Pharma Marketing, because it creates the opportunity to offer a large range of products across different health care systems.
Expertise
We understand each country’s regulatory entrance criteria are vital to have when striving to enter a market, as there are notable national differences and the success depends on the local status of product. e.g. Pharmaceuticals, Consumer Health, Medical Devices, Food Supplements, Cosmetics etc. Our Drug Regulatory Affairs experts focus to select right registration category and strategy and options for fast-track registrations and product labelling process. As we have expertise in regulatory affairs in emerging markets, we support in questions concerning registration.